The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival

The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival

The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech SurvivalNicole Coustier
Published on: 03/08/2024

Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.

U.S. Healthcare Fundamentals
Read more
What Do Payers Mean by “Clinical Utility”?

What Do Payers Mean by “Clinical Utility”?

What Do Payers Mean by “Clinical Utility”?Nicole Coustier
Published on: 01/06/2024

“Clinical utility” is one of the most misunderstood payer terms. This article explains what U.S. payers expect and how to prepare.

Evidence Planning
Read more